These policy tracking tables provide details about changes to alcohol and cannabis retail regulations during the pandemic.
Summarizes consultations with people who use or have used substances, their families and friends, harm reduction workers and people providing peer support services.
Describes the availability of take-home naloxone programs in Canada and the steps required to make naloxone available without a prescription.
This report is based on focus groups conducted by CCSA with young people to better understand approaches to messaging about alcohol consumption and harm reduction.
Rand Teed wears many hats as an international certified prevention specialist, a Canadian certified addiction counsellor and registered recovery coach.
Outlines CCSA’s activities in fiscal year 2024-2025 and provides the auditor’s report. It highlights different ways we were recognized as a trustworthy expert – an honest broker in polarized times – and called upon to inform substance use health…
Substance Abuse Librarians & Information Specialists (SALIS) and the Association of Mental Health Librarians (AMHL) cordially invite you to the 5th Annual Joint SALIS/AMHL Conference & the 42nd Annual SALIS International Conference to be…
New research shows that the contents of drugs from the unregulated supply remain unpredictable. In fact, there’s often a difference between what drugs people think they are taking and what they are actually consuming. This increases the risk of…
Examines the issues and misconceptions around substance use by older adults. Experts contribute chapters on epidemiology, the aging brain, the consequences of substance use by older adults, co-occurring health conditions, screening and assessment…
Examines data of cannabis use among Canadian youth in order to increase understanding of youth perceptions and inform prevention interventions.
Join the Fresh Outlook Foundation (FOF) and people from all sectors, ages, cultures, abilities, and genders for the virtual HEADS UP! Community Mental Health Summit November 25/26.
Submitted to the Standing Committee on Health on Women’s Health in October 2022.
